Torthaí cuardaigh - Lukas Theo Schmitt

  • 1 - 5 toradh as 5 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Prediction of designer-recombinases for DNA editing with generative deep learning

    Prediction of designer-recombinases for DNA editing with generative deep learning de réir Lukas Theo Schmitt, Maciej Paszkowski‐Rogacz, Florian Jug, Frank Buchholz

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Circulating tumour cells in patients with lung cancer universally indicate poor prognosis

    Circulating tumour cells in patients with lung cancer universally indicate poor prognosis de réir Fukang Jin, Lei Zhu, Jingbo Shao, Mina Yakoub, Lukas Theo Schmitt, Christoph Reißfelder, Sonja Loges, Axel Benner, Sebastian Schölch

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Efficient Correction of Oncogenic <i>KRAS</i> and <i>TP53</i> Mutations through CRISPR Base Editing

    Efficient Correction of Oncogenic <i>KRAS</i> and <i>TP53</i> Mutations through CRISPR Base Editing de réir Shady Sayed, Olga Alexandra Sidorova, Alexander Hennig, Martina Augsburg, Catherine P. Cortés Vesga, Moustafa Abohawya, Lukas Theo Schmitt, Duran Sürün, Daniel E. Stange, Jovan Mircetic, Frank Buchholz

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    A large-scale resource for tissue-specific CRISPR mutagenesis in Drosophila

    A large-scale resource for tissue-specific CRISPR mutagenesis in Drosophila de réir Fillip Port, Claudia Strein, Mona Stricker, Benedikt Rauscher, Florian Heigwer, Jun Zhou, Celine Beyersdörffer, Jana Frei, Amy Hess, Katharina Kern, Laura Lange, Nora Langner, Roberta Malamud, Bojana Pavlović, Kristin Rädecke, Lukas Theo Schmitt, Lukas Voos, Erica Valentini, Michael Boutros

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models

    The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models de réir Romain Sigaud, Lisa Rösch, Charlotte Gatzweiler, Julia Benzel, Laura von Soosten, Heike Peterziel, Florian Selt, Sara Najafi, Simay Ayhan, Xenia F. Gerloff, Nina Hofmann, Isabel Büdenbender, Lukas Theo Schmitt, Kathrin I. Foerster, Jürgen Burhenne, Walter E. Haefeli, Andrey Korshunov, Felix Sahm, Cornelis M. van Tilburg, David Jones, Stefan M. Pfister, Deborah Knoerzer, Brent Kreider, Max Sauter, Kristian W. Pajtler, Marc Zuckermann, Ina Oehme, Olaf Witt, Till Milde

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: